Clinical Trial Update: CAR-NK Cells (CL-NK-003) in Pancreatic Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial of CAR-NK cells CL-NK-003 for pancreatic cancer is currently recruiting. The sponsor is Changhai Hospital.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• CAR-NK Cells (CL-NK-003)

Snippet

Sponsor: Changhai Hospital | Conditions: Pancreatic Cancer | Phase 1 | Status: RECRUITING